Alcon Inc. (ALC) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $79.94. It has a SharesGrow Score of 72/100, indicating a above average investment profile with 4 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of ALC = $153.96 (+92.6% from the current price, the stock appears undervalued). Analyst consensus target is ALC = $91 (+13.9% upside).
Valuation: ALC trades at a trailing Price-to-Earnings (P/E) of 38.4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.74.
Financials: revenue is $10.4B, +6.1%/yr average growth. Net income is $980M, growing at +63.8%/yr. Net profit margin is 9.4% (thin). Gross margin is 55.2% (+0.7 pp trend).
Balance sheet: total debt is $5.2B against $22.0B equity (Debt-to-Equity (D/E) ratio 0.24, conservative). Current ratio is 2.12 (strong liquidity). Debt-to-assets is 16.6%. Total assets: $31.6B.
Analyst outlook: 14 / 26 analysts rate ALC as buy (54%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 44/100 (Partial), Growth 83/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 80/100 (Pass), Future 52/100 (Partial), Income 45/100 (Partial).
